Strides Shasun rises on receiving USFDA approval for Omega-3-Acid Ethyl Esters capsules

20 Sep 2017 Evaluate

Strides Shasun is currently trading at Rs. 1030.45, up by 22.30 points or 2.21% from its previous closing of Rs. 1008.15 on the BSE.

The scrip opened at Rs. 1022.00 and has touched a high and low of Rs. 1040.00 and Rs. 1015.00 respectively. So far 34,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1259.00 on 03-Feb-2017 and a 52 week low of Rs. 848.50 on 24-May-2017.

Last one week high and low of the scrip stood at Rs. 1040.00 and Rs. 964.70 respectively. The current market cap of the company is Rs. 9,213.00 crore.

The promoters holding in the company stood at 31.12%, while Institutions and Non-Institutions held 49.40% and 19.47% respectively.

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Omega-3-Acid Ethyl Esters Softgel capsules, a generic version of Lovaza. The US market for the generic Lovaza is approximately $300 million per annum, as per IMS, with five generic players including Par Pharmaceutical (Par), an Endo International Company.

The company has partnered with Par to market the product in the United States. The product to be manufactured in its flagship facility in Bangalore will be launched immediately.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.


Strides Pharma Scien Share Price

882.80 -4.30 (-0.48%)
11-Dec-2025 11:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1796.00
Dr. Reddys Lab 1268.20
Cipla 1501.55
Zydus Lifesciences 922.85
Lupin 2073.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×